These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21535387)

  • 21. High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome.
    Casina VC; Hu W; Mao JH; Lu RN; Hanby HA; Pickens B; Kan ZY; Lim WK; Mayne L; Ostertag EM; Kacir S; Siegel DL; Englander SW; Zheng XL
    Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9620-5. PubMed ID: 26203127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino acid regions 572-579 and 657-666 of the spacer domain of ADAMTS13 provide a common antigenic core required for binding of antibodies in patients with acquired TTP.
    Luken BM; Turenhout EA; Kaijen PH; Greuter MJ; Pos W; van Mourik JA; Fijnheer R; Voorberg J
    Thromb Haemost; 2006 Sep; 96(3):295-301. PubMed ID: 16953270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura.
    Ferrari S; Palavra K; Gruber B; Kremer Hovinga JA; Knöbl P; Caron C; Cromwell C; Aledort L; Plaimauer B; Turecek PL; Rottensteiner H; Scheiflinger F
    Haematologica; 2014 Apr; 99(4):779-87. PubMed ID: 24241492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura.
    Tersteeg C; Schiviz A; De Meyer SF; Plaimauer B; Scheiflinger F; Rottensteiner H; Vanhoorelbeke K
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2336-42. PubMed ID: 26338302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
    Shenkman B; Einav Y
    Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura.
    Klaus C; Plaimauer B; Studt JD; Dorner F; Lämmle B; Mannucci PM; Scheiflinger F
    Blood; 2004 Jun; 103(12):4514-9. PubMed ID: 14976043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura.
    Halkidis K; Zheng XL
    J Thromb Haemost; 2022 Oct; 20(10):2197-2203. PubMed ID: 35842925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unraveling the immunologic response in thrombotic thrombocytopenic purpura.
    Knöbl P
    J Thromb Haemost; 2006 Nov; 4(11):2352-4. PubMed ID: 16938122
    [No Abstract]   [Full Text] [Related]  

  • 29. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura.
    Edgar CE; Terrell DR; Vesely SK; Wren JD; Dozmorov IM; Niewold TB; Brown M; Zhou F; Frank MB; Merrill JT; Kremer Hovinga JA; Lämmle B; James JA; George JN; Farris AD
    PLoS One; 2015; 10(2):e0117614. PubMed ID: 25671313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura.
    Ferrari S; Mudde GC; Rieger M; Veyradier A; Kremer Hovinga JA; Scheiflinger F
    J Thromb Haemost; 2009 Oct; 7(10):1703-10. PubMed ID: 19682238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease.
    Lämmle B; Kremer Hovinga JA; George JN
    Haematologica; 2008 Feb; 93(2):172-7. PubMed ID: 18245649
    [No Abstract]   [Full Text] [Related]  

  • 33. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.
    Bresin E; Gastoldi S; Daina E; Belotti D; Pogliani E; Perseghin P; Scalzulli PR; Paolini R; Marcenò R; Remuzzi G; Galbusera M
    Thromb Haemost; 2009 Feb; 101(2):233-8. PubMed ID: 19190804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.
    Zheng XL
    Annu Rev Med; 2015; 66():211-25. PubMed ID: 25587650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
    Tsai HM; Raoufi M; Zhou W; Guinto E; Grafos N; Ranzurmal S; Greenfield RS; Rand JH
    Thromb Haemost; 2006 May; 95(5):886-92. PubMed ID: 16676082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases.
    Rieger M; Mannucci PM; Kremer Hovinga JA; Herzog A; Gerstenbauer G; Konetschny C; Zimmermann K; Scharrer I; Peyvandi F; Galbusera M; Remuzzi G; Böhm M; Plaimauer B; Lämmle B; Scheiflinger F
    Blood; 2005 Aug; 106(4):1262-7. PubMed ID: 15890682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADAMTS13 and von Willebrand factor interactions.
    Zander CB; Cao W; Zheng XL
    Curr Opin Hematol; 2015 Sep; 22(5):452-9. PubMed ID: 26186678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins.
    Studt JD; Kremer Hovinga JA; Radonic R; Gasparovic V; Ivanovic D; Merkler M; Wirthmueller U; Dahinden C; Furlan M; Lämmle B
    Blood; 2004 Jun; 103(11):4195-7. PubMed ID: 14982879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura.
    Starke R; Machin S; Scully M; Purdy G; Mackie I
    Br J Haematol; 2007 Feb; 136(4):649-55. PubMed ID: 17367414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
    Roose E; Vidarsson G; Kangro K; Verhagen OJHM; Mancini I; Desender L; Pareyn I; Vandeputte N; Vandenbulcke A; Vendramin C; Schelpe AS; Voorberg J; Azerad MA; Gilardin L; Scully M; Dierickx D; Deckmyn H; De Meyer SF; Peyvandi F; Vanhoorelbeke K
    Thromb Haemost; 2018 Oct; 118(10):1729-1742. PubMed ID: 30235483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.